China · Delayed Price · Currency is CNY InventisBio Statistics
Total Valuation
InventisBio has a market cap or net worth of CNY 12.37 billion. The enterprise value is 10.86 billion.
| Market Cap | 12.37B |
| Enterprise Value | 10.86B |
Important Dates
The next confirmed earnings date is Saturday, March 28, 2026.
| Earnings Date | Mar 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InventisBio has 578.35 million shares outstanding. The number of shares has decreased by -0.07% in one year.
| Current Share Class | 578.35M |
| Shares Outstanding | 578.35M |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | -11.16% |
| Owned by Insiders (%) | 10.10% |
| Owned by Institutions (%) | 28.90% |
| Float | 397.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 331.43 |
| PB Ratio | 7.43 |
| P/TBV Ratio | 7.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -34.27 |
| EV / Sales | 290.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.23% and return on invested capital (ROIC) is -11.24%.
| Return on Equity (ROE) | -18.23% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -11.24% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.72% |
| Revenue Per Employee | 201,758 |
| Profits Per Employee | -1.71M |
| Employee Count | 168 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, InventisBio has paid 239,500 in taxes.
| Income Tax | 239,500 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.00% in the last 52 weeks. The beta is 0.09, so InventisBio's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | +23.00% |
| 50-Day Moving Average | 26.25 |
| 200-Day Moving Average | 31.12 |
| Relative Strength Index (RSI) | 38.98 |
| Average Volume (20 Days) | 13,360,648 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InventisBio had revenue of CNY 37.33 million and -316.84 million in losses. Loss per share was -0.55.
| Revenue | 37.33M |
| Gross Profit | 37.33M |
| Operating Income | -316.60M |
| Pretax Income | -316.60M |
| Net Income | -316.84M |
| EBITDA | -311.13M |
| EBIT | -316.60M |
| Loss Per Share | -0.55 |
Balance Sheet
The company has 1.53 billion in cash and 21.39 million in debt, with a net cash position of 1.51 billion or 2.62 per share.
| Cash & Cash Equivalents | 1.53B |
| Total Debt | 21.39M |
| Net Cash | 1.51B |
| Net Cash Per Share | 2.62 |
| Equity (Book Value) | 1.67B |
| Book Value Per Share | 2.88 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -848.21% |
| Pretax Margin | -848.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InventisBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.07% |
| Earnings Yield | -2.56% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |